NCT06762873 (Trans-Q DISE) is a EARLY_PHASE1 clinical trial of Drug Induced Sleep Endoscopy with PNS in Obstructive Sleep Apnea, sponsored by Lunair Medical.

Who is sponsoring NCT06762873?

NCT06762873 is sponsored by Lunair Medical.

What drugs are being tested in NCT06762873?

Interventions in NCT06762873: Drug Induced Sleep Endoscopy with PNS.

What condition does NCT06762873 study?

NCT06762873 studies Obstructive Sleep Apnea.

Is NCT06762873 still recruiting?

NCT06762873 is currently recruiting now. Last updated 3 September 2025.

Last reviewed 2025-09-03 · How we verify

NCT06762873: Trans-Q DISE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessment of OSA in Latin American and Response to Neuromod Therapy

Recruiting now EARLY_PHASE1 Last updated 3 September 2025

What this trial tests

EARLY_PHASE1 trial testing Drug Induced Sleep Endoscopy with PNS in Obstructive Sleep Apnea in 50 participants. Currently enrolling.

Timeline

21 November 2024

Primary endpoint
31 December 2024

31 December 2025

Quick facts

Lead sponsor	Lunair Medical
Phase	EARLY_PHASE1
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	50
Start date	21 November 2024
Primary completion	31 December 2024
Estimated completion	31 December 2025
Sites	1 location across Paraguay

Drugs / interventions tested

Drug Induced Sleep Endoscopy with PNS

Conditions studied

Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →

Sponsor

Lunair Medical

Who can join

18 and older, any sex, with Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to characterize the upper airway of Latin American subjects who have been diagnosed with moderate/severe obstructive sleep apnea (OSA) and assess response to a neuromodulation therapy to treat OSA.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Obstructive Sleep Apnea

Currently open trials in the same condition.

NCT07195253 — Oro-myofunctional Characteristics and Obstructive Sleep Apnea in Infants With Down Syndrome · recruiting
NCT07273019 — Tongue Muscular Assessment in Children With Sleep Disordered Breathing · NA · recruiting
NCT07447011 — Glaucoma Respsosne to Lifestyle Corrections in Sleep Apnea · NA · recruiting
NCT07397780 — RPMO2 Oximeter Accuracy During Sleep 1 Trial · active not recruiting
NCT06698809 — Obstructive Sleep Apnea Therapeutic Intervention for REsiDual Sleepiness · NA · recruiting

Other Lunair Medical trials

Trials by the same sponsor.

NCT07243405 — Neurostimulation for Sleep Disordered Breathing (SDB) · NA · recruiting
NCT06883617 — Neurostimulation for Sleep Disordered Breathing · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06762873 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Lunair Medical
Last refreshed: 3 September 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06762873.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing